and surveillance strategy, the overall incidence of VTE events among patients with acute SCI receiving no or suboptimal prophylaxis has been estimated as 4% to 100%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Decisionmaking regarding thromboprophylaxis for these patients is often complex. Many of the same factors, such as immobility, associated long-bone or pelvic fractures, post-traumatic inflammation, and the need for surgical intervention(s) that contribute to this vulnerability must also be taken into account when considering potential benefits and harms (particularly, bleeding) associated with available therapeutic modalities. Comorbid traumatic brain injury or visceral injury may further confound this calculus.
Interestingly, several studies suggest the highest incidence of VTE events occurs among patients with thoracic segment SCI. [14] [15] [16] [17] Studies also suggest that early initiation of prophylaxis and continuation for a period of approximately 3 mo postinjury are effective strategies for the prevention of VTE. 10, 16, 18, 19 Numerous published investigations report the results of individual or multiple, combined prophylactic measures. 8, 9, 11, 17, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] The regimens are sufficiently heterogeneous that few generalities can be advanced. In aggregate, these studies suggest that some prophylaxis is better than no prophylaxis and that while one pharmacologic agent may not be demonstrably superior to another, pharmacologic prophylaxis may be better than mechanical measures alone. Combination therapy may offer additional benefit beyond any singular modality. However, these same studies-while integral to any discussion of the indications for and potential benefits of thromboprophylaxis-share a lack of specificity that limits their applicability to the current investigation. Either "spinal cord injury" is equated with cervical segment pathology, injuries are not stratified by segment, or the investigators did not enroll a sufficient number of thoracic and lumbar segment injuries to warrant inclusion for this analysis.
Here, the authors address considerations specific to the occurrence of VTE events in the setting of thoracic and lumbar spine fractures. Three questions were posed: (1) does routine screening for DVT prevent PE in this population; (2) is one regimen of DVT prophylaxis superior to others with respect to prevention of PE; and, (3) is there a specific treatment regimen for documented VTE that provides fewer complications than other treatments in this population?
METHODS
Details of the systematic literature review are provided in the full text of this guideline (https://www.cns.org/guideline-chapters/congressneurological-surgeons-systematic-review-evidence-based-guidelines/ chapter_7) and in the methodology (https://www.cns.org/guidelinechapters/congress-neurological-surgeons-systematic-review-evidencebased-guidelines/chapter_1) article of this guideline series. The authors collaborated with a medical librarian to search for articles published from 1946 to March 31, 2015. Two electronic databases-PubMed and Cochrane-were searched, yielding a total of 697 and 21 references, respectively. The authors supplemented searches of electronic databases with manual screening of the bibliographies of all retrieved publications. Task force members reviewed all abstracts yielded from the literature search and identified those warranting full text review and extraction, in accordance with the Literature Search Protocol (Appendix I; https://www.cns.org/guideline-chapters/congress-neurological-surgeonssystematic-review-evidence-based-guidelines/chapter_7). Task force members identified the best research evidence available to answer the targeted clinical questions. When Level I, II, or III literature was available to answer specific questions, the task force did not review level IV studies. The guideline task force used a modified version of the North American Spine Society's evidence-based guideline development methodology for classification of evidence.
RESULTS
The literature search yielded 697 PubMed results. A separate Cochrane search produced 49 results which, after prescreening for non-English and duplicates, yielded 21 additional references, for a total of 718. After applying inclusion and exclusion criteria, the task force ultimately selected 60 articles for full text review. Among these selections, 28 were potentially applicable to question 2, 6 to question 1, and none to question 3. Of the 60 full-text articles, 59 were rejected for not meeting inclusion criteria or for being off topic (most for enrolling <80% patients with thoracolumbar segment injuries or not stratifying results by involved spine segment). One study-relevant to Question 2-was selected for inclusion in this systematic review.
A single study provides Level II evidence that while EPCC (external pneumatic calf compression) decreases the incidence of DVT, the combination of mechanical and pharmacologic prophylaxis (aspirin and dipyridamole) results in a greater reduction. Green et al. published a prospective study comparing mechanical and combined pharmacologic/mechanical regimens for the prevention of DVT in patients with SCI. 33 Twenty-eight consecutive patients with "lower limb paralysis" were randomized to receive either EPCC or EPCC in combination with aspirin (300 mg 2 times daily) and dipyridamole (75 mg 3 times daily) for the first 30 d postinjury. Overall, DVT was detected in 9/27 (33%) patients analyzed (1 was lost to transfer). This was significant as compared with the 78% DVT rate observed previously in a cohort of 37 patients who received no prophylaxis. The use of EPCC lowered the rate to 40%, while the addition of aspirin and dipyridamole lowered the rate further to 25%. This study was downgraded from Level I to Level II in recognition of multiple deficiencies: method of randomization not reported, lack of blinding, no power analysis, inadequate reporting of baseline data, no post-treatment assessment, and a discussion referencing untreated "controls" from a previously published study.
DISCUSSION
Ultimately, only 1 article was identified that met inclusion criteria for any of the 3 questions posed. This study provides level II evidence applicable to question 2. This now 34-yrold publication reports on a pharmacologic regimen that would be considered "historical" in 2016. Still, the suggestion that combined pharmacologic and mechanical prophylaxis might provide a benefit over mechanical alone is consistent with available literature for the broader topic of "acute spinal cord injury."
The absence of sufficient evidence to permit discrete recommendations should not be construed as an indication to forego screening or prophylaxis for this acknowledged high-risk group. Rather, this conclusion merely reflects strict adherence to methodology. The literature search strategy for this topic was designed to restrict results to the specific subpopulation of patients with injury to the thoracic or lumbar segments. Most published studies on the topic of VTE prophylaxis in the setting of SCI fail either to distinguish between patients presenting with tetraplegia or paraplegia or to stratify injury by spine segment. The great majority of potentially relevant articles were excluded for failure to reach 80% thoracolumbar injury threshold alone. If a wider net is cast to encompass "acute spinal cord injury" as a general subject term, there exists ample evidence, predominantly Level III, but with some Level I and II studies, for the use of DVT prophylaxis.
CONCLUSION
In summary, there is insufficient evidence to provide discrete recommendations regarding VTE prophylaxis for the specific population of patients presenting with thoracic and lumbar spine injuries. However, the consensus of the work group-on the basis of pooled spinal cord populations-is that thromboprophylaxis is recommended.
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